Published in J Clin Invest on January 01, 1980
Biosynthesis and metabolism of 1,4-diaminobutane, spermidine, spermine, and related amines. Adv Enzymol Relat Areas Mol Biol (1972) 2.71
Physiology of the natural polyamines putrescine, spermidine and spermine. Med Biol (1975) 2.09
SPERMIDINE AND SPERMINE IN RAT TISSUES AT DIFFERENT AGES. Acta Physiol Scand (1964) 1.45
Selective polyamine-binding proteins. Spermine binding by an androgen-sensitive phosphoprotein. Biochim Biophys Acta (1978) 1.37
Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. Arch Phys Med Rehabil (1957) 1.30
Polyamines and the accumulation of RNA in mammalian systems. Fed Proc (1970) 1.25
Amine synthesis in regenerating rat liver: effect of hypophysectomy and growth hormone on ornithine decarboxylase. Endocrinology (1969) 1.25
Changes in polyamine content of rat liver following hypophysectomy and treatment with growth hormone. Biochem Biophys Res Commun (1966) 1.24
Metabolic effects of plasmin digests of human growth hormone in the rat and man. J Clin Invest (1973) 1.12
Measurement of putrescine, spermidine, and spermine in physiological fluids by use of an amino acid analyzer. Clin Chem (1973) 1.07
Observations on the responsiveness of human subjects to human growth hormone. Effects of endogenous growth hormone deficiency and myotinic dystrophy. J Clin Invest (1971) 1.05
Effect of polyamines on a ribonuclease which hydrolyzes ribonucleic acid at uridylic acid residues. J Biol Chem (1973) 1.00
A study of the reproducibility of muscle testing and certain other aspects of muscle scoring. Phys Ther Rev (1954) 0.98
Metabolic effects of human growth hormone and of estrogens in boys with Duchenne muscular dystrophy. J Clin Invest (1972) 0.90
Hyper-responsiveness of patients with limb-girdle dystrophy to human growth hormone. J Clin Endocrinol Metab (1972) 0.84
Hyperresponsivness of patients with clinical and premyopathic myotonic dystrophy to human growth hormone. J Clin Endocrinol Metab (1977) 0.81
Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science (1996) 3.84
A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST) N Engl J Med (1994) 3.73
Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol (1997) 3.44
HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity (2001) 3.43
Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. Biometrics (1996) 2.78
Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell (2001) 2.39
An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat Struct Biol (1998) 2.24
A randomized, controlled trial of the distal splenorenal shunt. Ann Surg (1978) 2.15
Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology (1988) 2.06
A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem (1997) 2.00
Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology (1978) 1.97
Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc Natl Acad Sci U S A (1997) 1.91
Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol (2000) 1.79
Selective and total shunts in the treatment of bleeding varices. A randomized controlled trial. N Engl J Med (1976) 1.77
Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med (1990) 1.75
Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest (1981) 1.69
CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proc Natl Acad Sci U S A (1999) 1.67
Measurement of liver and spleen volume by computed tomography. Assessment of reproducibility and changes found following a selective distal splenorenal shunt. Radiology (1981) 1.65
Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Gen Virol (2000) 1.62
Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial. Ann Surg (1986) 1.62
Nasal mucus clearance in nasal and para nasal sinus disorders. Indian J Chest Dis Allied Sci (1989) 1.52
The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg (1985) 1.50
The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor. J Immunol (1988) 1.49
V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1. J Virol (1999) 1.49
HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J Exp Med (2001) 1.45
Stability of refraction during four years after radial keratotomy in the prospective evaluation of radial keratotomy study. Am J Ophthalmol (1991) 1.45
Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt--effect on survival? Ann Surg (1983) 1.42
Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue. J Virol (2000) 1.39
JAK/STAT signaling by cytokine receptors. Curr Opin Immunol (1998) 1.36
Results of the Prospective Evaluation of Radial Keratotomy (PERK) Study five years after surgery. The Perk Study Group. Ophthalmology (1991) 1.33
Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J Virol (2001) 1.33
Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects. J Clin Invest (1973) 1.32
Children with normal-variant short stature: treatment with human growth hormone for six months. N Engl J Med (1981) 1.31
Prevalence of growth hormone deficiency in children with cleft lip or palate. J Pediatr (1978) 1.28
Variations in glucose metabolism and sensitivity to insulin of the rat's adipose tissue, in relation to age and body weight. Endocrinology (1968) 1.24
Quantitative prediction of drug toxicity in humans from toxicology in small and large animals. Cancer Res (1975) 1.22
The metabolic basis of portasystemic encephalopathy and the effect of selective vs nonselective shunts. Ann Surg (1974) 1.19
Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg (1992) 1.18
Hemodynamics during liver transplantation: the interactions between cardiac output and portal venous and hepatic arterial flows. Hepatology (1992) 1.17
Assessing depression and anxiety in chronic dialysis patients. J Psychosom Res (1985) 1.17
First-order clearance of plasma galactose: the effect of liver disease. Gastroenterology (1982) 1.17
Protein-calorie undernutrition in hospitalized cancer patients. Am J Med (1980) 1.16
Effect of free fatty acids on binding of drugs by bovine serum albumin, by human serum albumin and by rabbit serum. J Pharmacol Exp Ther (1971) 1.16
Elemental balances during intravenous hyperalimentation of underweight adult subjects. J Clin Invest (1975) 1.16
Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation. Curr Biol (1997) 1.16
Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity. Proc Natl Acad Sci U S A (1995) 1.16
Metabolic approaches to cancer cachexia. Annu Rev Nutr (1982) 1.15
Megadose vitamins. Use and misuse. N Engl J Med (1983) 1.14
S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha. Biochem J (1999) 1.13
Metabolic effects of plasmin digests of human growth hormone in the rat and man. J Clin Invest (1973) 1.12
End-stage renal disease treatment modality and patients' quality of life. Longitudinal assessment. Am J Nephrol (1986) 1.12
Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease. J Virol (2000) 1.10
Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status. J Virol (2001) 1.10
Sources of variability in echocardiographic measurements. Am J Cardiol (1980) 1.09
How is the liver primed or sensitized for alcoholic liver disease? Alcohol Clin Exp Res (2001) 1.09
Novel proteins and peptides in the urine of patients with advanced neoplastic disease. Am J Med (1969) 1.09
A trans-receptor mechanism for infection of CD4-negative cells by human immunodeficiency virus type 1. Curr Biol (1999) 1.07
The molecular role of the common gamma c subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes. Proc Natl Acad Sci U S A (1996) 1.06
Characterization of autostimulatory and transforming growth factors from human melanoma cells. Cancer Res (1985) 1.05
Observations on the responsiveness of human subjects to human growth hormone. Effects of endogenous growth hormone deficiency and myotinic dystrophy. J Clin Invest (1971) 1.05
Technical pitfalls in measurement of venous plasma NH3 concentration. Clin Chem (1976) 1.04
Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J Virol (2000) 1.04
Hyperalimentation of the cancer patient with protein-calorie undernutrition. Cancer Res (1981) 1.02
Undernutrition in the nursing home: prevalence, consequences, causes and prevention. Nutr Rev (1994) 1.02
Effect of growth hormone and oxandrolone singly and together on growth rate in girls with X chromosome abnormalities. J Pediatr (1980) 1.02
Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection. J Virol (1998) 1.02
N,O-Diacetylserine1 alpha-melanocyte-stimulating hormone, a naturally occurring melanotropic peptide. J Biol Chem (1979) 1.01
Plasma cysteine, cystine, and glutathione in cirrhosis. Gastroenterology (1984) 1.01
Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line. Cancer Res (1983) 1.01
Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels. J Am Geriatr Soc (1995) 1.01
Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J Biol Chem (1998) 0.99
A clinical trial of strengthening and aerobic exercise to improve gait and balance in elderly male nursing home residents. Am J Phys Med Rehabil (1992) 0.99
Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology (1981) 0.99
Cleavage of bovine insulin by rat adipose tissue. Endocrinology (1966) 0.97
Structural variants of human growth hormone: biochemical, genetic, and clinical aspects. Annu Rev Med (1983) 0.97
Observations on the nitrogen metabolism of patients with portal cirrhosis. Am J Clin Nutr (1970) 0.97
Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity. J Biol Chem (1996) 0.97
Hypocitraturia in calcium nephrolithiasis. J Clin Endocrinol Metab (1982) 0.97
Hypocitraturia in patients with gastrointestinal malabsorption. N Engl J Med (1980) 0.96
Distal splenorenal shunt for management of variceal bleeding in patients with schistosomal hepatic fibrosis. Ann Surg (1986) 0.96
Hyperdibasicaminoaciduria, hyperammonemia, and growth retardation: Treatment with arginine, lysine, and citrulline. J Pediatr (1975) 0.96
Deficiency of carnitine in cachectic cirrhotic patients. J Clin Invest (1977) 0.96
A new method for isolating the nonidentical protein subunits of human plasma alpha-lipoprotein. J Clin Invest (1970) 0.96
Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus. Curr Biol (1998) 0.95
Shared gamma(c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency. J Clin Invest (1997) 0.95
Screening for cognitive impairment in older individuals. Validation study of a computer-based test. Arch Neurol (1994) 0.95
Stimulatory effect of inflammatory cytokines on alpha 1-antichymotrypsin expression in human lung-derived epithelial cells. J Clin Invest (1995) 0.94
Observations on the protein components of human plasma high- and low-density lipoproteins. Biochemistry (1968) 0.94